ArticleActa crystallographica Section B, Structural science, crystal engineering and materials2014
Validation of molecular crystal structures from powder diffraction data with dispersion-corrected density functional theory (DFT-D).
Article in Acta crystallographica Section B, Structural science, crystal engineering and materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed.
- Structure of metaraminol hydrogen tartrate from synchrotron X-ray data and density functional theory calculations.Acta crystallographica. Section E, Crystallographic communications · 2026Article
- Article
- Crystal structure of seladelpar, CActa crystallographica. Section E, Crystallographic communications · 2026Article
- Best practices in `0 K' DFT energy calculations on molecular crystal structures.Acta crystallographica. Section C, Structural chemistry · 2026Article
- Crystal structure of the (1Acta crystallographica. Section E, Crystallographic communications · 2026Article
- Crystal structure of clofarabine (form I), CActa crystallographica. Section E, Crystallographic communications · 2026Article
- Avutometinib.Acta crystallographica. Section E, Crystallographic communications · 2026Article
- Levosimendan Form I, CActa crystallographica. Section E, Crystallographic communications · 2026Article
- Crystal structure of sunvozertinib, CActa crystallographica. Section E, Crystallographic communications · 2026Article
- Midodrine hydro-chloride Form A, CActa crystallographica. Section E, Crystallographic communications · 2026Article
- Crystal structure of binimetinib (Form A), CActa crystallographica. Section E, Crystallographic communications · 2026Article
- 5-Amino-levulinic acid hydro-chloride.IUCrData · 2026Article
- Bepostastine besylate.IUCrData · 2026Article
- Structure of racemic calcium 5-methyl-tetra-hydrofolate trihydrate from synchrotron powder diffraction data and density functional theory.Acta crystallographica. Section E, Crystallographic communications · 2026Article
- A good-practice guide to solving and refining molecular organic crystal structures from laboratory powder X-ray diffraction data.Acta crystallographica. Section C, Structural chemistry · 2025Article
- Structure of entinostat Form B, CActa crystallographica. Section E, Crystallographic communications · 2025Article
- Benchmarking quantum chemical methods with X-ray structures via structure-specific restraints.IUCrJ · 2025Article
- Structure Determination of Tegoprazan((Molecules (Basel, Switzerland) · 2025Article
- Large-Scale Parameter Estimation for Crystal Structure Prediction. Part 1: Dataset, Methodology, and Implementation.Journal of chemical theory and computation · 2024Article
- Hydrogen bonding patterns and C-H...π interactions in the structure of the antiparkinsonian drug (R)-rasagiline mesylate determined using laboratory and synchrotron X-ray powder diffraction data.Acta crystallographica Section B, Structural science, crystal engineering and materials · 2023Article
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2010 we energy-minimized 225 high-quality single-crystal (SX) structures with dispersion-corrected density functional theory (DFT-D) to establish a quantitative benchmark. For the current paper, 215 organic crystal structures determined from X-ray powder diffraction (XRPD) data and published in an IUCr journal were energy-minimized with DFT-D and compared to the SX benchmark. The on average slightly less accurate atomic coordinates of XRPD structures do lead to systematically higher root mean square Cartesian displacement (RMSCD) values upon energy minimization than for SX structures, but the RMSCD value is still a good indicator for the detection of structures that deserve a closer look. The upper RMSCD limit for a correct structure must be increased from 0.25 Å for SX structures to 0.35 Å for XRPD structures; the grey area must be extended from 0.30 to 0.40 Å. Based on the energy minimizations, three structures are re-refined to give more precise atomic coordinates. For six structures our calculations provide the missing positions for the H atoms, for five structures they provide corrected positions for some H atoms. Seven crystal structures showed a minor error for a non-H atom. For five structures the energy minimizations suggest a higher space-group symmetry. For the 225 SX structures, the only deviations observed upon energy minimization were three minor H-atom related issues. Preferred orientation is the most important cause of problems. A preferred-orientation correction is the only correction where the experimental data are modified to fit the model. We conclude that molecular crystal structures determined from powder diffraction data that are published in IUCr journals are of high quality, with less than 4% containing an error in a non-H atom.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.